Cesarean Section Clinical Trial
— MODEOfficial title:
Misoprostol With Mechanical Dilation Versus Oxytocin With Mechanical Dilation for High-risk Pregnancy Inductions: A Randomized Control Trial
NCT number | NCT04492072 |
Other study ID # | 20D.435 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 17, 2020 |
Est. completion date | May 26, 2022 |
Verified date | June 2022 |
Source | Thomas Jefferson University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to specifically investigate whether oxytocin and mechanical dilation decreases the rate of cesarean section compared to misoprostol and mechanical dilation for pregnancies at risk of fetal compromise
Status | Completed |
Enrollment | 150 |
Est. completion date | May 26, 2022 |
Est. primary completion date | May 26, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - • Age > 18 years old - Singleton, or twins with demise of one - Cephalic presentation - Intact membranes - Hypertension (chronic hypertension, gestational hypertension, pre-eclampsia with/without severe features, superimposed preeclampsia with/without severe features, eclampsia, HELLP) - Oligohydramnios (AFI< 5cm and/or MVP <2cm) - Fetal growth restriction (EFW or AC <10th percentile) with normal or abnormal (elevated, absent, or reversed) Umbilical Artery Dopplers - Abnormal antenatal fetal testing (NST, Biophysical profile, decreased fetal movement) prompting induction of labor - Suspected placental abruption - Poorly controlled pre-gestational diabetes, defined as >50% abnormal glucose values requiring increasing doses of anti-glycemic agents >34 weeks, or requiring delivery - Gestational Age > 22 weeks - Bishop score < 6 Exclusion Criteria: - • Prior cesarean delivery - Allergy to misoprostol - Allergy to oxytocin - Allergy to silicone/latex - Contraindication to vaginal delivery including placenta or vasa previa, Placenta accreta/increta/percreta, prior uterine rupture, Prior myomectomy entering the uterine cavity and necessitating cesarean delivery, active genital herpes, transverse or oblique fetal lie, umbilical cord prolapse, or HIV viral load >1000 copies/mL |
Country | Name | City | State |
---|---|---|---|
United States | Thomas Jefferson University Hospital | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Thomas Jefferson University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of Cesarean Delivery | Total rate of cesarean delivery | 48 hours | |
Secondary | The time interval from induction-to-delivey for vaginal deliveries | Maternal outcome | 48 hours | |
Secondary | The number of vaginal births within 24 hours | Maternal outcome | 24 hours | |
Secondary | The number of misoprostol doses received by each participant | Maternal outcome | 24 hours | |
Secondary | The incidence of uterine tachysystole | Defined as greater than 5 contractions in a ten minute window, averaged over 30 minutes | 24 hours | |
Secondary | The rate of each indication for the cesarean delivery | Indications include non-reassuring fetal hear tones, arrest of dilation, arrest in the 2nd stage of labor etc. | 48 hours | |
Secondary | The rate of operative vaginal delivery | Maternal outcome - includes forceps or vacuum assisted deliveries | 48 hours | |
Secondary | The rate of intra-amniotic infection | Maternal outcome | 48 hours | |
Secondary | The rate of postpartum hemorrhage | Maternal outcome | 24 hours | |
Secondary | The rate of Fetal heart rate abnormaliies | recurrent late decelerations, bradycardia, or prolonged deceleration | 48 hours | |
Secondary | The number of patients that received betamethasone for fetal lung maturity and/or magnesium sulfate for fetal neuroprotection | Maternal outcome | 24 hours | |
Secondary | The rate of stillbirth | Fetal/Neonatal outcome | 48 hours | |
Secondary | The total rate of Neonatal Apgar scores less than 7 at 5 minutes | Neonatal outcome | 5 minutes | |
Secondary | The total rate of Neonatal RDS | Neonatal outcome | 96 hours | |
Secondary | The total rate of Neonatal admission to the NICU | Neonatal outcome | 96 hours | |
Secondary | The total rate of neonatal arterial umbilical blood pH < 7.1 | Neonatal outcome | 96 hours | |
Secondary | The rate of neonatal Sepsis | Neonatal outcome | 96 hours | |
Secondary | The rate of Neonatal Death | Neonatal outcome | 96 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03631329 -
Predictability of Preoperative Carotid Artery Corrected Flow Time for Hypotension After Spinal Anesthesia in Patients Undergoing Cesarean Section
|
||
Completed |
NCT03244540 -
Regional Analgesia After Cesarean Section
|
Phase 4 | |
Active, not recruiting |
NCT03760718 -
Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery
|
Early Phase 1 | |
Active, not recruiting |
NCT04965779 -
The Effect of Abdominal Binder Use on Postpartum Pain, Bleeding, and Breastfeeding Success in Cesarean Delivery Women
|
N/A | |
Terminated |
NCT01687972 -
INSORB Versus Subcuticular Sutures at Cesarean Section
|
Phase 1 | |
Withdrawn |
NCT01211431 -
Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine
|
Phase 4 | |
Completed |
NCT00991627 -
Different Approaches to Maternal Hypotension During Cesarean Section
|
Phase 4 | |
Completed |
NCT00987701 -
Perineuraxial Anesthesia Fluid Management and Infant Neurobehaviors
|
N/A | |
Completed |
NCT01049477 -
The Effects of Music Therapy on Women's Anxiety Before and During Cesarean Delivery
|
N/A | |
Terminated |
NCT00524511 -
Comparison Study of Wound Closure at Time of Cesarean Delivery: Dermabond Glue Versus Surgical Staples
|
N/A | |
Terminated |
NCT00386477 -
Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial
|
N/A | |
Completed |
NCT00375986 -
A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section
|
N/A | |
Completed |
NCT00517140 -
Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function
|
N/A | |
Terminated |
NCT05051150 -
Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Caesarean Section
|
Phase 4 | |
Terminated |
NCT03695172 -
Comparison of TAP, Anterior QL, or ESP Block for Elective Cesarean Section
|
Phase 4 | |
Recruiting |
NCT06247852 -
Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
|
||
Completed |
NCT06012747 -
Pain After Cesarean Section - A Danish Multicenter Cohort Study.
|
||
Not yet recruiting |
NCT05187520 -
Naldebain for Control of Post-Cesarean Section Pain
|
Phase 2 | |
Not yet recruiting |
NCT04999670 -
Fascial Closure and Post-caesarean Pain
|
N/A |